|
|
Bayer AG
OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/02/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization52,068 mln
Float982 mln
Earnings Date08/04/2026
Key Fundamentals
EPS-2.49
ROE-7.61
RPS53.56
ROIC7.80
ROA-2.11
Interest Cover3.58
EBITDA, mln3,377
EV / EBITDA25.42
EV / EBIT925
Revenue, mln52,615
EV / Revenue1.66
Financial Strength
Altman Z-Score0.79
Piotroski F-Score
7
/ 9
Beneish M-Score-2.78
Price to Intrinsic Value0.90
Shiller PE Ratio52.31
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
11.42% |
88
/ 100
 |
| 1 Month |
35.01% |
96
/ 100
 |
| 2 Months |
9.09% |
67
/ 100
 |
| 6 Months |
96.5% |
93
/ 100
 |
| 1 Year |
145% |
91
/ 100
|
|
| |
